Healthcare Overhaul Bill Slated to Be Considered by Full House

Drug Industry Daily
A A
The House scheduled a vote over the weekend on healthcare overhaul legislation that includes a 12-year exclusivity period for manufacturers of brand biologics and several other measures important to drugmakers.

To View This Article:

Login

Subscribe To Drug Industry Daily